UNSPSC 51331706: Remoxipride hydrochloride

This classification denotes a dopamine antagonist with the molecular formula C16H23BrN2O3.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MH4OU8RWCW, chemically known as (-)-(s)-3-bromo-n-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide monohydrochloride, monohydrate but more generally known as remoxipride hydrochloride, which bears US NIH Compound Identifier 60678. Most nations, for tariff and trade purposes, schedule remoxipride hydrochloride under HS 29339990 and SITC 51577.

As of Q4 2014, REMOXIPRIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Remoxipride hydrochloride bears US NLM identifiers UMLS ID C0771022 and NCI Concept Code C73832. SMILES: CCN1CCC[C@H]1CNC(=O)C2C(CCC(C2OC)BR)OC.O.CL.

UNSPSC 51331706 Remoxipride hydrochloride is a Commodity code that nominally covers a specific antipsychotic pharmaceutical, but recent state and local procurement activity under this code does not reflect actual purchases of remoxipride. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually — medications and harm-reduction equipment unrelated to the code's stated scope. The mismatch suggests either a tagging error in the county's procurement system or that the code is being used to classify opioid-antagonist and drug-disposal products more broadly rather than as a single-drug pharmaceutical identifier. State and local governments appear to use this code, at minimum, for public health and community safety acquisitions tied to substance-use response and prevention.

Seminole County's naloxone and drug deactivation procurement represents the only recent state-local opportunity visible under this code. The IFB called for quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with electronic bid submission through the county's e-Procurement Portal and a response deadline of July 26, 2023. The contract includes a two-year initial term with a one-year renewal option, E-Verify compliance, and drug-free workplace certification requirements. FEMA funding was potentially involved, introducing federal regulatory compliance obligations. The lack of additional recent opportunities suggests this code sees limited state and local solicitation activity, or that counties and municipalities tagging similar acquisitions use alternative UNSPSC codes for pharmaceutical and medical-supply procurements.